A novel methylation signature predicts extreme long-term survival in glioblastoma. Decraene B, Coppens G, Spans L, Solie L, et al. J Neurooncol 2024 Jun 19. doi: 10.1007/s11060-024-04741.

Read + Share

Amedeo Smart

Independent Medical Education

Decraene B, Coppens G, Spans L, Solie L, et al. A novel methylation signature predicts extreme long-term survival in glioblastoma. J Neurooncol 2024 Jun 19. doi: 10.1007/s11060-024-04741.
PMID: 38898218